EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 416 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

*

Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines

Cihan Yurdaydın ¹ , Fehmi Tabak ¹ , Sabahattin Kaymakoğlu ¹ , Mesut Akarsu ¹ , Esra G. Akıncı ¹ , Hikmet Akkız ¹ , Canan Alkım ¹ , Ayhan H. Çekin ¹ , Nefise Ö. Çuvalcı ¹ , Kadir Demir ¹ , Bülent Değertekin ¹ , İlyas Dökmetaş ¹ , Galip Ersöz ¹ , Kenan Hizel ¹ , Fatma Ö. Kandemir ¹ , Yusuf Önlen ¹ , Abdullah Sonsuz ¹ , Ebubekir Şenateş ¹ , Selma Tosun ¹ , Nurdan Tözün ¹ , Ramazan Idilman ¹ , and Viral Hepatisis Guideline Study Group ¹

Author Affiliation(s)

1.

Turkish Association for the Study of the Liver, Istanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey

Turk J Gastroenterol 2017; 28: Supplement 84-89

DOI: 10.5152/tjg.2017.20

Read: 2391 Downloads: 1151 Published: 25 July 2019

Volume 28, Issue 2, December 2017

Previous Article

Abstract

Cite this article as: Yurdaydın C, Tabak F, Idilman R; Viral Hepatitis Guidelines Study Group. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines. Turk J Gastroenterol 2017; 28(Suppl 2); S84-S89.

Files